HomeAFP • ASX
add
AFT Pharmaceuticals Ltd
Previous close
$2.50
Day range
$2.60 - $2.60
Year range
$2.15 - $3.16
Market cap
289.43M NZD
Avg Volume
2.31K
P/E ratio
-
Dividend yield
-
Primary exchange
NZE
Market news
Financials
Income Statement
Revenue
Net income
(NZD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 60.65M | 8.51% |
Operating expense | 18.03M | 15.03% |
Net income | 7.07M | 2.57% |
Net profit margin | 11.66 | -5.51% |
Earnings per share | — | — |
EBITDA | 10.70M | -4.97% |
Effective tax rate | 26.58% | — |
Balance Sheet
Total assets
Total liabilities
(NZD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 11.11M | -7.72% |
Total assets | 169.82M | 2.76% |
Total liabilities | 72.74M | -6.10% |
Total equity | 97.08M | — |
Shares outstanding | 104.87M | — |
Price to book | 2.69 | — |
Return on assets | 14.32% | — |
Return on capital | 19.13% | — |
Cash Flow
Net change in cash
(NZD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | 7.07M | 2.57% |
Cash from operations | 4.41M | -58.76% |
Cash from investing | -1.51M | 35.67% |
Cash from financing | -2.61M | 28.99% |
Net change in cash | 212.00K | -95.51% |
Free cash flow | 4.87M | 13.69% |
About
Founded
1997
Website
Employees
119